Subscribe
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
TESTIMONY
Remarks to the European Parliament on EFSD/ EFSD+
September 24, 2025
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPER
October 06, 2025
Antimicrobial resistance (AMR) represents one of the most pressing global health challenges, yet translating scientific evidence into effective policy has proven slow, uneven, and fragmented across contexts. To inform the design of a proposed Independent Panel for Evidence for Action (IPEA) against ...
WORKING PAPER
October 01, 2025
The Intergovernmental Panel on Climate Change has become a reference point for the design of international scientific advisory bodies. This paper examines what lessons from its experience may inform the creation of a new global panel on antimicrobial resistance. Drawing on interviews, roundtable dis...
WORKING PAPER
May 21, 2025
Antimicrobial resistance (AMR) is a growing global threat that demands coordinated, cross-sectoral action rooted in rigorous evidence and inclusive governance. In response to calls for an independent panel on evidence for action on AMR, this policy paper presents insights from a global consultation ...
WORKING PAPER
January 29, 2025
This study estimates the costs of four key interventions to mitigate antimicrobial resistance globally by 2050. These interventions include improving access to water, sanitation, and hygiene, enhancing childhood vaccination, developing new antibiotics, and increasing access to healthcare and existin...
WORKING PAPER
January 29, 2025
This study estimates the global inpatient healthcare costs attributable to antimicrobial resistance (AMR) and projects future expenditures across different scenarios. It finds that AMR accounts for 25.4 million hospital admissions annually, resulting in $66.4 billion in excess healthcare costs, with...
WORKING PAPER
January 29, 2025
Antimicrobial resistance (AMR) poses a major global challenge, affecting both human health and economies. This research models the potential impacts of AMR on global GDP and various sectors, showing that while better treatment and combined interventions can boost economic growth, accelerated resista...
BRIEF
September 30, 2024
Antimicrobial resistance (AMR) is responsible for a large and growing burden of mortality, morbidity, and economic impacts. This is due to three underlying problems: lack of access to essential antimicrobials, insufficient stewardship of these drugs to prevent overuse and misuse, and a dearth of inn...
